1. Home
  2. NBHC vs NNNN Comparison

NBHC vs NNNN Comparison

Compare NBHC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBHC

National Bank Holdings Corporation

N/A

Current Price

$39.65

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$21.18

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NBHC
NNNN
Founded
2009
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
NBHC
NNNN
Price
$39.65
$21.18
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$45.33
N/A
AVG Volume (30 Days)
464.5K
42.1K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
3.19%
N/A
EPS Growth
N/A
N/A
EPS
2.85
N/A
Revenue
$47,100,000.00
N/A
Revenue This Year
$39.32
N/A
Revenue Next Year
$6.74
N/A
P/E Ratio
$14.11
$446.57
Revenue Growth
2.86
N/A
52 Week Low
$32.83
$5.91
52 Week High
$42.99
$55.65

Technical Indicators

Market Signals
Indicator
NBHC
NNNN
Relative Strength Index (RSI) 42.30 41.30
Support Level $37.79 $19.25
Resistance Level $40.97 $30.70
Average True Range (ATR) 1.13 2.16
MACD -0.19 -0.20
Stochastic Oscillator 19.01 6.00

Price Performance

Historical Comparison
NBHC
NNNN

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: